|
STK35 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
1.66511999999397E-05 |
| Normal-vs-Stage3 |
8.37280245136185E-11 |
| Normal-vs-Stage4 |
4.28910018612783E-10 |
| Stage1-vs-Stage2 |
2.102800E-01 |
| Stage1-vs-Stage3 |
2.872800E-01 |
| Stage1-vs-Stage4 |
6.512000E-01 |
| Stage2-vs-Stage3 |
6.714600E-01 |
| Stage2-vs-Stage4 |
4.440000E-01 |
| Stage3-vs-Stage4 |
6.639800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.0106999681625E-09 |
| Normal-vs-Asian |
1.047260E-04 |
| Caucasian-vs-AfricanAmerican |
4.239200E-01 |
| Caucasian-vs-Asian |
7.834800E-01 |
| AfricanAmerican-vs-Asian |
9.664200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-16 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
4.458300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.36390000000397E-05 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.64301905414277E-12 |
| Normal-vs-Age(81-100Yrs) |
2.445800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.372200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.250800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.426800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.525380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.432960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.333600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.188400E-04 |
| Normal-vs-Grade 2 |
1.62447832963153E-12 |
| Normal-vs-Grade 3 |
6.32716101733877E-13 |
| Normal-vs-Grade 4 |
1.91699989215977E-10 |
| Grade 1-vs-Grade 2 |
1.899440E-01 |
| Grade 1-vs-Grade 3 |
4.999500E-02 |
| Grade 1-vs-Grade 4 |
8.717500E-02 |
| Grade 2-vs-Grade 3 |
8.232400E-02 |
| Grade 2-vs-Grade 4 |
5.295600E-01 |
| Grade 3-vs-Grade 4 |
5.025400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.33226762955019E-15 |
| Normal-vs-ccB subtype |
9.10382880192628E-15 |
| ccA subtype-vs-ccB subtype |
8.718800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62592161956354E-12 |
| Normal-vs-N1 |
6.318600E-03 |
| N0-vs-N1 |
3.198800E-01 |
|
|
